On March 27, 2026, Dyadic International, Inc. received a deficiency notice from the Nasdaq Listing Qualifications staff, indicating that the company is out of compliance with the technical minimum requirements for continued listing under Nasdaq Listing Rule 5550(b). This rule mandates that companies maintain at least one of the following: $2.5 million in stockholders' equity, $35 million in market value of listed securities, or $500,000 of net income from continuing operations. The notice does not immediately affect the listing of Dyadic's common stock on the Nasdaq Capital Market. The company has until May 11, 2026, to submit a plan to regain compliance. If accepted, Dyadic may be granted a cure period of up to 180 days to meet the requirements. Additionally, the company is also out of compliance with the minimum bid price requirement of $1.00, with a deadline to regain compliance by June 17, 2026. Failure to cure either deficiency could lead to delisting from Nasdaq. Dyadic plans to actively monitor its compliance and evaluate options to resolve the deficiency, likely through the stockholders' equity requirement. The company has a history of net losses and faces challenges in market acceptance of its technologies, which adds to the uncertainty surrounding its compliance efforts.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.